Lv11
38 积分 2024-09-18 加入
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan–cyclophosphamide versus busulfan–cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial
4小时前
已完结
Genome-wide CRISPR/Cas9 library screening identified OGDH as a regulator of disease progress and resistance to decitabine in myelodysplastic neoplasm by reprogramming glutamine metabolism
5小时前
已完结
Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia
6天前
已完结
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
7天前
已完结
IL-1R1 and IL-18 Signals Regulate Mesenchymal Stromal Cells in an Aged Murine Model of Myelodysplastic Syndromes
7天前
已完结
T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development
8天前
已完结
Malignant progression of preleukemic disorders
17天前
已完结
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses
23天前
已完结
<i>Ex vivo</i> drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with <i>PICALM::MLLT10</i>
24天前
已完结
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
1个月前
已完结
皖公网安备34019202002308
